United Kingdom of Great Britain and Northern Ireland

Last Updated 26 July 2021.

4 Vaccines Approved for Use in United Kingdom of Great Britain and Northern Ireland

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 64 countries

  21 trials in 4 countries

  Approval Source: bbc.com

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 97 countries

  24 trials in 16 countries

  Approval Source: nytimes.com

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  11 trials in 17 countries

  Approval Source: bbc.com

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 119 countries

  33 trials in 19 countries

  Approval Source: astrazeneca.com

  Non Replicating Viral Vector

9 Vaccines in Clinical Trials in United Kingdom of Great Britain and Northern Ireland

• Novavax
  NVX-CoV2373

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  7 trials in 7 countries

  Protein Subunit

• Medicago
  Plant-based VLP

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  3 trials in 5 countries

  VLP

• Curevac
  CVnCoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  10 trials in 12 countries

  RNA

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 64 countries

  21 trials in 4 countries

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 97 countries

  24 trials in 16 countries

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  11 trials in 17 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 119 countries

  33 trials in 19 countries

  Non Replicating Viral Vector

• Valneva
  VLA2001

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  5 trials in 1 country

  Inactivated

• Codagenix Inc
  COVI-VAC

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Live-Attenuated

1 Vaccines with Trials in United Kingdom of Great Britain and Northern Ireland are No Longer Progressing

• Imperial
  LNP-nCoVsaRNA

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  1 trial in 1 country

  RNA